phenalen-1-one has been researched along with Leishmaniasis in 2 studies
*Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL). [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abad-Grillo, T; Cabrera-Serra, MG; Fernández-Pérez, L; Luis, JG; Martín-Rodríguez, P; McNaughton-Smith, G; Piñero, JE; Rosquete, LI | 1 |
| Abad-Grillo, T; Bethencourt-Estrella, CJ; Chiboub, O; Freijo, MB; López-Arencibia, A; Lorenzo-Morales, J; McNaughton-Smith, G; Piñero, JE; Reyes-Batlle, M; Rizo-Liendo, A; Sifaoui, I | 1 |
2 other study(ies) available for phenalen-1-one and Leishmaniasis
| Article | Year |
|---|---|
Synthesis and in vitro antiprotozoal evaluation of substituted phenalenone analogues.
Topics: Antiprotozoal Agents; Cell Line, Tumor; Humans; Leishmaniasis; Pentamidine; Phenalenes; Trypanosoma cruzi; Trypanosomiasis | 2010 |
In vitro activity of 1H-phenalen-1-one derivatives against Leishmania spp. and evidence of programmed cell death.
Topics: Antiprotozoal Agents; Apoptosis; Humans; Leishmania; Leishmaniasis; Life Cycle Stages; Molecular Structure; Phenalenes | 2019 |